These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9533068)

  • 1. Carvedilol use in heart failure.
    Neal CP; Kendrach MG
    Ann Pharmacother; 1998 Mar; 32(3):376-81. PubMed ID: 9533068
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carvedilol in cardiac decompensation].
    Dib J
    Rev Med Liege; 1996 Feb; 51(2):198-200. PubMed ID: 8650455
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carvedilol therapy in pediatric patients with Takayasu's arteritis complicated with congestive heart failure: a case report].
    Wu XY; Song HM; Wei M
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):315-6. PubMed ID: 19555579
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy.
    Öcal L; Çakir H; Tellice M; İzci S; Alizade E; Esen AM
    Herz; 2015 Feb; 40(1):159-61. PubMed ID: 24173375
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacogenetics and heart failure: a convergence with carvedilol.
    Meadowcroft AM; Williamson KM; Patterson JH; Pieper JA
    Pharmacotherapy; 1997; 17(4):637-9. PubMed ID: 9250542
    [No Abstract]   [Full Text] [Related]  

  • 6. Carvedilol in heart failure: the MOCHA trial.
    Osterziel KJ
    Circulation; 1997 Oct; 96(8):2742; author reply 2743-4. PubMed ID: 9355927
    [No Abstract]   [Full Text] [Related]  

  • 7. Blood pressure and the therapy of advanced heart failure.
    Cohn JN
    J Am Coll Cardiol; 2004 Apr; 43(8):1430-1. PubMed ID: 15093879
    [No Abstract]   [Full Text] [Related]  

  • 8. Major heart failure news from 2001.
    Francis D
    Heart Fail Monit; 2002; 2(4):147-8. PubMed ID: 12638556
    [No Abstract]   [Full Text] [Related]  

  • 9. [Carvedilol and heart failure: new findings].
    Cosín Aguilar J
    Rev Esp Cardiol; 1996 Feb; 49(2):85-7. PubMed ID: 8948716
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting response to carvedilol for the treatment of heart failure: a multivariate retrospective analysis.
    Schleman KA; Lindenfeld JA; Lowes BD; Bristow MR; Ferguson D; Wolfel EE; Abraham WT; Zisman LS
    J Card Fail; 2001 Mar; 7(1):4-12. PubMed ID: 11264544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol.
    Kida K; Yoneyama K; Kobayashi Y; Takano M; Akashi YJ; Miyake F
    Int J Cardiol; 2013 Sep; 168(2):1588-9. PubMed ID: 23416019
    [No Abstract]   [Full Text] [Related]  

  • 12. Carvedilol for heart failure.
    Med Lett Drugs Ther; 1997 Sep; 39(1010):89-91. PubMed ID: 9323960
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy with beta blockers in heart failure. Recent studies of carvedilol].
    Böhm M; Erdmann E
    Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of clinical efficacy in studies of heart failure.
    Rector TS
    Circulation; 1998 Feb; 97(7):707. PubMed ID: 9495309
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
    Bosimini E
    Ital Heart J Suppl; 2001 Aug; 2(8):919-21. PubMed ID: 11582729
    [No Abstract]   [Full Text] [Related]  

  • 16. Carvedilol [Coreg].
    Kukin M
    Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
    [No Abstract]   [Full Text] [Related]  

  • 17. Carvedilol and dose-related improvements in left ventricular function.
    Ghali JK
    Circulation; 1997 Oct; 96(8):2743-4. PubMed ID: 9355928
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study.
    Rouleau JL; Roecker EB; Tendera M; Mohacsi P; Krum H; Katus HA; Fowler MB; Coats AJ; Castaigne A; Scherhag A; Holcslaw TL; Packer M;
    J Am Coll Cardiol; 2004 Apr; 43(8):1423-9. PubMed ID: 15093878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of carvedilol on mortality risk in heart failure patients with diabetes: results of a meta-analysis.
    Bell DS; Lukas MA; Holdbrook FK; Fowler MB
    Curr Med Res Opin; 2006 Feb; 22(2):287-96. PubMed ID: 16466600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.